RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Shanghai Fosun Pharmaceutical Group Co Stock

Shanghai Fosun Pharmaceutical Group Co Dividend 2024

Shanghai Fosun Pharmaceutical Group Co Dividend

0.42 CNY

Shanghai Fosun Pharmaceutical Group Co Dividend yield

1.57 %

Ticker

600196.SS

ISIN

CNE000000X38

How much dividend does Shanghai Fosun Pharmaceutical Group Co 2024 pay?

According to the latest status from December 2024, Shanghai Fosun Pharmaceutical Group Co paid a total of 0.42 CNY per share in dividends within the last 12 months. With the current Shanghai Fosun Pharmaceutical Group Co price of 26.68 CNY, this corresponds to a dividend yield of 1.57 %. A dividend is paid times per year.

1.57 % Dividend Yield=
0.42 CNY Dividend
26.68 CNY Stock Price

Historical Shanghai Fosun Pharmaceutical Group Co Dividends

A dividend is paid times per year. Last year, the payout months were and September.

PaydateDividend
9/6/20240.27
9/9/20230.42
7/16/20220.56
8/19/20210.43
8/30/20200.39
9/2/20190.32
9/3/20180.38
9/9/20170.35
7/23/20160.32
9/12/20150.28
9/19/20140.27
9/19/20130.21
7/11/20120.1
8/11/20110.1
8/26/20100.07
9/19/20090.1
8/10/20080.1
7/8/20070.08
5/26/20060.34
7/21/20050.15
1
2

Shanghai Fosun Pharmaceutical Group Co dividend history and estimates

In 2023, Shanghai Fosun Pharmaceutical Group Co paid a dividend amounting to 0.42 CNY. Dividend means that Shanghai Fosun Pharmaceutical Group Co distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Shanghai Fosun Pharmaceutical Group Co provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Shanghai Fosun Pharmaceutical Group Co’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Shanghai Fosun Pharmaceutical Group Co's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Shanghai Fosun Pharmaceutical Group Co Dividend History

DateShanghai Fosun Pharmaceutical Group Co Dividend
2026e0.44 undefined
2025e0.44 undefined
2024e0.44 undefined
20230.42 undefined
20220.56 undefined
20210.43 undefined
20200.39 undefined
20190.32 undefined
20180.38 undefined
20170.35 undefined
20160.32 undefined
20150.28 undefined
20140.27 undefined
20130.21 undefined
20120.1 undefined
20110.1 undefined
20100.07 undefined
20090.07 undefined
20080.07 undefined
20070.05 undefined
20060.17 undefined
20050.08 undefined
20040.1 undefined

Is the Shanghai Fosun Pharmaceutical Group Co Dividend Safe?

Shanghai Fosun Pharmaceutical Group Co has been increasing the dividend for 4 years.

Over the past 10 years, Shanghai Fosun Pharmaceutical Group Co has increased it by an annual 7.177 %.

Over a five-year period, the distribution increased by 2.022%.

Analysts expect a Dividend Increase of 2.856% for the current fiscal year.

Shanghai Fosun Pharmaceutical Group Co dividend payout ratio

In 2023, Shanghai Fosun Pharmaceutical Group Co had a payout ratio of 29.89%. The payout ratio indicates the percentage of the company's profits that Shanghai Fosun Pharmaceutical Group Co distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Shanghai Fosun Pharmaceutical Group Co represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Shanghai Fosun Pharmaceutical Group Co could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Shanghai Fosun Pharmaceutical Group Co's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Shanghai Fosun Pharmaceutical Group Co Payout Ratio History

DateShanghai Fosun Pharmaceutical Group Co Payout ratio
2026e31.31 %
2025e33.27 %
2024e30.77 %
202329.89 %
202239.14 %
202123.27 %
202027.27 %
201924.62 %
201835.51 %
201727.56 %
201626.67 %
201526.42 %
201429.35 %
201329.58 %
201214.29 %
201116.39 %
201014.49 %
20094.94 %
200818.02 %
200715.08 %
2006124.54 %
200576.92 %
200478.9 %

Dividend Details

Understanding Shanghai Fosun Pharmaceutical Group Co's Dividend Distributions

Shanghai Fosun Pharmaceutical Group Co’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining Shanghai Fosun Pharmaceutical Group Co's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

Shanghai Fosun Pharmaceutical Group Co's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in Shanghai Fosun Pharmaceutical Group Co’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

Shanghai Fosun Pharmaceutical Group Co Aktienanalyse

What does Shanghai Fosun Pharmaceutical Group Co do?

Shanghai Fosun Pharmaceutical Group Co Ltd is a Chinese company specializing in the healthcare industry. It was founded in 1994 and is headquartered in Shanghai. The company has grown to become one of the largest pharmaceutical conglomerates in China and operates internationally. The company's history began in the 1990s with the establishment of Shanghai Fosun High-Tech (Group) Co. Ltd. Through the acquisition of local pharmaceutical companies, Fosun quickly secured a place among the major players in the Chinese pharmaceutical market. From the beginning, the development, production, and marketing of pharmaceutical products and medical devices were the main focus. Today, Shanghai Fosun Pharmaceutical is a holding company with various subsidiaries operating in different areas of medicine. These include the development of innovative drugs, the production of generic drugs, and the business-to-consumer sector. The company generates an annual revenue of over six billion US dollars. One of Shanghai Fosun Pharmaceutical's most well-known products is the drug Alunbrig for the treatment of lung cancer. It is a tyrosine kinase inhibitor that inhibits the growth of cancer cells. Alunbrig has shown good results in clinical studies and is now approved for the treatment of lung cancer in many countries. Another important business area for Shanghai Fosun Pharmaceutical is the production of generic drugs. These are imitations of already approved, often expensive, original drugs. Fosun manufactures such medications at a significantly lower cost than the original manufacturer, making them more accessible to a broader population. In addition to drug development and generic production, Shanghai Fosun Pharmaceutical is also active in other areas of the healthcare industry. In recent years, the company has acquired several private hospitals in China and operates them under the name Fosun International Hospitals. Special emphasis is placed on state-of-the-art medical technology and patient-oriented care. Another important area is the manufacturing of medical devices. Shanghai Fosun Pharmaceutical works closely with partners from both domestic and foreign markets to develop innovative products. An example is the artificial hip joint, which was developed in collaboration with an American partner company. Fosun produces and distributes over 70 different types of medical devices. In summary, Shanghai Fosun Pharmaceutical Group is an innovative company specializing in various areas of the healthcare industry. Through its consistent focus on growth and innovation, Fosun has steadily expanded in recent years and has become one of the key players in the Chinese pharmaceutical market. However, the global expansion and ambitious goals also leave room for risks and mistakes. Shanghai Fosun Pharmaceutical Group Co is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Frequently Asked Questions about Shanghai Fosun Pharmaceutical Group Co stock

How much dividend does Shanghai Fosun Pharmaceutical Group Co pay?

Over the past 12 months, Shanghai Fosun Pharmaceutical Group Co paid a dividend of 0.42 CNY . This corresponds to a dividend yield of about 1.57 %. For the coming 12 months, Shanghai Fosun Pharmaceutical Group Co is expected to pay a dividend of 0.44 CNY.

What is the dividend yield of Shanghai Fosun Pharmaceutical Group Co?

The current dividend yield of Shanghai Fosun Pharmaceutical Group Co is 1.57 %.

When does Shanghai Fosun Pharmaceutical Group Co pay dividends?

Shanghai Fosun Pharmaceutical Group Co pays a quarterly dividend. This is distributed in the months of August, July, September, September.

How secure is the dividend of Shanghai Fosun Pharmaceutical Group Co?

Shanghai Fosun Pharmaceutical Group Co paid dividends every year for the past 23 years.

What is the dividend of Shanghai Fosun Pharmaceutical Group Co?

For the upcoming 12 months, dividends amounting to 0.44 CNY are expected. This corresponds to a dividend yield of 1.66 %.

In which sector is Shanghai Fosun Pharmaceutical Group Co located?

Shanghai Fosun Pharmaceutical Group Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Shanghai Fosun Pharmaceutical Group Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Shanghai Fosun Pharmaceutical Group Co from 8/6/2024 amounting to 0.27 CNY, you needed to have the stock in your portfolio before the ex-date on 8/6/2024.

When did Shanghai Fosun Pharmaceutical Group Co pay the last dividend?

The last dividend was paid out on 8/6/2024.

What was the dividend of Shanghai Fosun Pharmaceutical Group Co in the year 2023?

In the year 2023, Shanghai Fosun Pharmaceutical Group Co distributed 0.56 CNY as dividends.

In which currency does Shanghai Fosun Pharmaceutical Group Co pay out the dividend?

The dividends of Shanghai Fosun Pharmaceutical Group Co are distributed in CNY.

Andere Kennzahlen von Shanghai Fosun Pharmaceutical Group Co

Our stock analysis for Shanghai Fosun Pharmaceutical Group Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Shanghai Fosun Pharmaceutical Group Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.